Litcius/Paper detail

Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials

Paolo Tarantino, Sara Gandini, Dario Trapani, Carmen Criscitiello, Giuseppe Curigliano

2021Critical Reviews in Oncology/Hematology106 citationsDOI

Topics & Concepts

MedicineTriple-negative breast cancerInternal medicineOncologyBreast cancerRandomized controlled trialImmunotherapyMeta-analysisAnthracyclineClinical endpointNeoadjuvant therapySubgroup analysisChemotherapyCancerBreast Cancer Treatment StudiesCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials | Litcius